In BP-NEN, a decline in GPER expression was observed with increased grading, a negative correlation was identified with the Ki-67 index, and positive correlations were observed with patient outcomes and markers associated with a good prognosis, indicating that GPER acts as a tumour suppressor and may also serve as prognostic marker. The gene discussed is GPER1; the disease is neoplasm.